50 results
Page 2 of 3
8-K
EX-2.1
uqqeh64rxdhtcv
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
8-K
EX-10.1
yl08 iirrwtlipty1
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
EX-10.1
7pqw5kjc
6 Jan 21
EyeGate Enters Into Agreement for $8.0 Million Private Placement
6:55am
8-K
EX-2.1
90pgbupyf79akaxaw
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
8-K
EX-10.1
uht90
31 Dec 19
EyeGate Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
EX-10.1
uwpu98fgi53mk1
30 Sep 19
EyeGate Enters Into Agreement for $1.9 Million Private Placement
6:55am
PRE 14A
iybgcnf
17 May 18
Preliminary proxy
5:21pm
8-K
EX-10.1
4crjo 9z78
13 Apr 18
EyeGate Announces $11.25 Million Public Offering
12:00am